---
$id: https://graph.org.ai/products/commodity/51384628
$type: Product
source: UNSPSC
code: "51384628"
title: "Mofebutazone sodium"
class: "51384600"
classTitle: "Nonsteroidal anti inflammatory pyrazoles"
family: "51380000"
familyTitle: "Nonsteroidal anti inflammatory drugs NSAIDs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mofebutazone sodium

**UNSPSC Code**: 51384628
**Class**: [Nonsteroidal anti inflammatory pyrazoles](Nonsteroidal anti inflammatory pyrazoles.mdx)
**Family**: [Nonsteroidal anti inflammatory drugs NSAIDs](../Nonsteroidal anti inflammatory drugs NSAIDs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a nonsteroidal antiinflammatory drug C13H15N2O2.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 73X92I1U1W, chemically known as 3,5-pyrazolidinedione, 4-butyl-1-phenyl-, sodium salt (1:1), but more generally known as mofebutazone sodium, which bears US NIH Compound Identifier 16639. European Medicines Agency schedules Mofebutazone sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03313MIG. Most nations, for tariff and trade purposes, schedule mofebutazone sodium under HS 29331990 and SITC 51571. As of Q4 2014, MOFEBUTAZONE SODIUM remains US FDA's Preferred Term for this commodity. SMILES: CCCC[C-]1C(=O)[NH]N(C1=O)C2CCCCC2.[NA+].

